Novo Nordisk A/S / Fundamentals

    Income statement

    Net revenue
    €41.77B
    Cost of goods sold
    €6.70B
    Gross profit
    €35.06B
    SG&A expenses
    €9.62B
    R&D expenses
    €6.06B
    EBITDA
    €22.58B
    D&A
    €2.46B
    EBIT
    €19.13B
    Interest expenses
    €1.47B
    EBT
    €18.85B
    Tax expenses
    €3.98B
    Net income
    €14.87B

    Cash flow statement

    Net deferred tax
    €2.26B
    Non-cash items
    -€104.98M
    Changes in working capital
    -€3.20B
    Operating cash flow
    €16.27B
    Capex
    €7.97B
    Other investing cash flow
    -€433.29M
    Net investing cash flow
    -€17.81B
    Total cash dividends paid
    -€6.79B
    Issuance of common stock
    €0.00
    Debt repayment
    -€629.85M
    Other financing cash flow
    €5.94B
    Net financing cash flow
    -€2.99B
    Foreign exchange effects
    -€70.56M
    Net change in cash
    -€4.60B
    Cash at end of period
    €2.47B
    Free cash flow
    €24.24B

    Balance sheet

    Cash and cash equivalents
    €2.47B
    Cash and short-term investments
    €2.54B
    Total receivables
    €11.49B
    Inventory
    €6.11B
    Other current assets
    €1.64B
    Total current assets
    €21.79B
    Property, plant & equipment
    €24.20B
    Goodwill
    €0.00
    Intangible assets
    €14.44B
    Long-term investments
    €353.22M
    Other non-current assets
    €594.37M
    Total non-current assets
    €42.77B
    Total assets
    €64.56B
    Accounts payable
    €3.78B
    Short-term debt
    €1.60B
    Other current liabilities
    €20.14B
    Total current liabilities
    €27.79B
    Long-term debt
    €11.69B
    Deferred tax liabilities
    €1.31B
    Other non-current liabilities
    €1.27B
    Total non-current liabilities
    €14.27B
    Total liabilities
    €42.06B
    Common stock
    €59.72M
    Retained earnings
    €22.02B
    Other equity
    €424.32M
    Total equity
    €22.50B
    Total liabilities and shareholders' equity
    €64.56B

    Company information

    Market capitalization
    €258.73B
    Employees
    77K
    Enterprise Value
    €2.40T

    Company ratios

    Gross margin
    83.9% Much better than peer group: -187,944.4%
    EBITDA margin
    54.1% Much better than peer group: -3,612.5%
    EBIT margin
    45.8% Much better than peer group: -3,799.7%
    EBT margin
    45.1% Much better than peer group: -19,051.0%
    Net margin
    35.6% Much better than peer group: -3,814.2%
    ROE
    66.1% Much better than peer group: -28.4%
    ROA
    23.0% Much better than peer group: -49.9%
    Asset turnover
    64.7% Much better than peer group: 23.9%
    FCF margin
    19.9% Much better than peer group: -2,881.7%
    FCF yield
    3.2%
    Efficiency ratio
    45.9%
    Net sales per employee
    €539.59K
    Net income per employee
    €192.13K

    Notifications